You searched for "infection"
Raphaél Ervinckx joins Glaukos
Glaukos Corporation has appointed Raphaél Ervinckx as Vice President and General Manager for the EMEAI region, marking a strategic move to support the company’s continued international growth. Raphaël Ervinckx brings extensive experience in the ophthalmology sector, most recently serving as...Heidelberg Engineering joins the Collaborative Community on Ophthalmic Innovation (CCOI) through EssilorLuxottica’s Vision Architect membership
Heidelberg Engineering announced that it is joining the Collaborative Community on Ophthalmic Innovation (CCOI) as part of its parent company EssilorLuxottica’s Vision Architect membership – CCOI’s highest level of industry participation. CCOI is a public–private forum that convenes patients, clinicians,...Surgitrac Instruments to Exhibit at UKISCRS Cornea & Cataract Day
Surgitrac Instruments is pleased to announce its participation in the United Kingdom & Ireland Society of Cataract and Refractive Surgeons (UKISCRS) Cornea & Cataract Day 2026, taking place on 16 March in Edinburgh. The event brings together leading ophthalmic professionals...TowardPi BMizar: Revolutionising Ophthalmic Imaging with Ultra High-Speed Precision
A powerful ophthalmic imaging system that establishes a new benchmark in optical coherence tomography (OCT) and OCT angiography (OCTA). Engineered with an ultra high speed 400 kHz swept source, this device delivers rapid, highly detailed scans of both the anterior...Corza Medical at SARCS 2026
Corza Medical attended the XXIV State of the Art Refractive & Cataract Surgery (SARCS) meeting in June, joining ophthalmologists, researchers, and industry leaders committed to advancing patient care through innovation and collaboration. The meeting provided an important opportunity to exchange...Digital eyecare – enabling better communication between primary and secondary care
Alexander Chiu and his co-authors highlight innovations influencing healthcare advancement and how trainees can get involved. Hospital eye services (HES) were under great pressure to meet demand, even before the COVID-19 pandemic. This pressure has increased with the cancellation and...
Pilot trial of Fluoxetine for post-stroke homonymous hemianopia
The authors present a pilot randomised placebo controlled double blind trial assessing 20mg fluoxetine once daily for 90 days versus placebo in stroke survivors with isolated homonymous hemianopia. Exclusion criteria were extensive in terms of pre-existing ophthalmic or neurologic disease,...100% Ophthalmology 2027
100% Ophthalmology / 100% Optical TradeshowThe value of hospital placements in ophthalmology in general practice specialty training
Pratik Bikkannavar provides insights into the potential benefits a placement in ophthalmology provides General Practice Specialty Trainees (GPSTs) and its valuable purpose for the wider ophthalmic community. Ophthalmic complaints are known to account for up to 1 in every 20...New partnership to prevent unnecessary sight loss
Sight loss charity the Macular Society has announced a new partnership with OcuPlan, a service designed to give patients with long-term eye conditions such as macular disease affordable access to specialist care to prevent unnecessary sight loss.
